Product Information

SELEGILINE HCL 5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.7925 per EA under NDC 60505343803. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 6, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SELEGILINE HCL 5 MG TABLET

Selegiline Hydrochloride
$0.7925per EA

Strength

5 mg/1

Manufacturer

Apotex Corp.

NDC

60505343803

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SELEGILINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074871

FDA Approved

6/6/1997

TE Code

AB

On Market Since

7/6/1997

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors
Monoamine Oxidase Type B Inhibitor
Monoamine Oxidase-B Inhibitors

Price Statistics

The NADAC for SELEGILINE HCL 5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 53.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7925 per EA
All-time high$2.1399 (Jul 16, 2014)
All-time low$0.6101 (Jul 17, 2024)
52-week high$0.8788
52-week low$0.6895
Median price$1.1025
Average price$1.1394
Largest weekly change+42.1% (Oct 18, 2017)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.4%

1M

-0.4%

3M

+4.5%

6M

+13.2%

1Y

-9.8%

3Y

-12.9%

5Y

-26.7%

All

-53.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SELEGILINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG TABLET, manufactured by Apotex Corp., is $0.7925 per EA (NDC 60505343803), effective Aug 19, 2026.

How has the price of SELEGILINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG TABLET has declined 53.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for SELEGILINE HCL 5 MG TABLET has ranged from a low of $0.6101 (Jul 17, 2024) to a high of $2.1399 (Jul 16, 2014), with a median of $1.1025 per EA.

Are there cheaper alternatives to SELEGILINE HCL 5 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SELEGILINE HCL 5 MG TABLET, is $0.6101 per EA — about 23% below SELEGILINE HCL 5 MG TABLET.

Who manufactures SELEGILINE HCL 5 MG TABLET?

SELEGILINE HCL 5 MG TABLET (NDC 60505343803) is labeled by Apotex Corp., and CMS classifies it as a generic product.